Alerts will be sent to your verified email
Verify EmailFILTRA
|
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.05 % | 20.43 % | -2.16 % |
|
5yr average Equity Multiplier
|
1.85 | 1.65 | 1.43 |
|
5yr Average Asset Turnover Ratio
|
2.36 | 2.43 | 1.33 |
|
5yr Avg Net Profit Margin
|
3.2 % | 5.25 % | 0.06 % |
|
Price to Book
|
2.77 | 1.09 | 34.55 |
|
P/E
|
23.14 | 6.21 | 46.57 |
|
5yr Avg Cash Conversion Cycle
|
36.46 Days | 8.07 Days | 362.19 Days |
|
Inventory Days
|
55.87 Days | 4.2 Days | 0.0 |
|
Days Receivable
|
34.62 Days | 51.03 Days | 362.19 Days |
|
Days Payable
|
66.81 Days | 42.28 Days | 18.78 Days |
|
5yr Average Interest Coverage Ratio
|
65.13 | 13.94 | -272.71 |
|
5yr Avg ROCE
|
19.83 % | 29.7 % | -0.79 % |
|
5yr Avg Operating Profit Margin
|
4.39 % | 4.13 % | 1.78 % |
|
5 yr average Debt to Equity
|
0.02 | 0.1 | 0.06 |
|
5yr CAGR Net Profit
|
9.36 % | 16.09 % | 24.57 % |
|
5yr Average Return on Assets
|
7.6 % | 12.42 % | -1.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.45 % | 47.64 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.73 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|